乳酸是疑似ST段抬高型心肌梗死入院患者的预后因素
该研究在2247例连续疑似STEMI患者中,对2094例(93%)于入院时测定乳酸浓度,评估其对30天死亡率的预后价值。在多变量模型中,乳酸在外周低灌注体征、收缩压和左心室射血分数之外提供额外预后信息,与30天死亡率独立相关(HR 1.11,95%CI 1.07-1.14,P<0.0001)。乳酸联合外周低灌注体征、收缩压和LVEF预测30天死亡的ROC曲线下面积为0.88,高于三者单独的0.83(P<0.0001)。作者结论认为入院乳酸在疑似STEMI患者中具有预后价值,推荐STEMI患者测定乳酸,尤其存在血流动力学受损体征时。
要点
- 疑似STEMI患者入院乳酸与外周低灌注体征、收缩压、LVEF联合时,30天死亡预测AUC为0.88,高于三者单独的0.83(P<0.0001)。
- 校正外周低灌注体征、收缩压和LVEF后,入院乳酸仍独立与30天死亡率相关(HR 1.11,95%CI 1.07-1.14,P<0.0001)。
- 作者推荐对STEMI患者测定乳酸,尤其当存在血流动力学受损体征时。
- 该研究在2247例连续疑似STEMI患者中,2094例(93%)于入院时测定了乳酸浓度。
适用人群与场景
- 连续疑似ST段抬高型心肌梗死(STEMI)入院患者,共2247例,其中2094例(93%)入院时测定乳酸浓度。
研究设计与关键结果
- 研究类型为在2247例连续疑似STEMI患者中评估入院乳酸浓度对30天死亡率预后价值的研究,其中2094例(93%)测定了入院乳酸。
- 在多变量模型中,乳酸在外周低灌注体征、收缩压和LVEF之外提供预后信息,与30天死亡率独立相关(HR 1.11,95%CI 1.07-1.14,P<0.0001)。
- 乳酸联合外周低灌注体征、收缩压和LVEF预测30天死亡的AUC为0.88,三者单独为0.83(P<0.0001)。
证据类型、等级与局限
- 证据类型:研究论文(连续疑似STEMI患者队列的预后分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者推荐对STEMI患者测定乳酸,尤其当存在血流动力学受损体征时;入院乳酸可在外周低灌注体征、收缩压和LVEF之外提供30天死亡预后信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: The diagnosis of cardiogenic shock depends on clinical signs of poor perfusion and low blood pressure. Lactate concentration will increase with poor tissue perfusion, and it has prognostic value in cardiogenic shock patients. We sought to assess the prognostic value of lactate concentration in subjects admitted with suspected ST-elevation myocardial infarction (STEMI).
METHODS AND RESULTS: In 2,094 (93%) out of 2,247 consecutive suspected STEMI-subjects, lactate concentration was measured on admission. The prognostic value of lactate concentration on 30-day mortality was assessed in addition to clinical signs of peripheral hypoperfusion, systolic blood pressure (sBP), and left ventricular ejection fraction (LVEF) in multivariable models.Lactate concentration added prognostic information beyond signs of peripheral hypoperfusion, sBP, and LVEF, and was independently associated with 30-day mortality (hazard ratio [95% confidence interval] 1.11 [1.07-1.14], P < 0.0001). Lactate also provided predictive information on 30-day mortality to the combination of signs of peripheral hypoperfusion, sBP, and LVEF (area under the receiver-operating characteristics curve = 0.88 vs. 0.83, P < 0.0001).
CONCLUSIONS: In conclusion, admission lactate concentration in suspected STEMI-subjects contains prognostic information on 30-day mortality when added to variables used in cardiogenic shock-definition. We recommend lactate measurement in STEMI-subjects, especially when signs of compromised hemodynamics are present.
参考来源
- Frydland M, Møller JE, Wiberg S, et al. Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction. Shock. 2019. PMID: 30286032. doi:10.1097/SHK.0000000000001191
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。